You browser is out of date and some functionality on this site may be not supported.
Please consider upgrading to the latest version of your browser for the best possible experience.
Kindly note that this website is not compatible with this browser. Some features may not work. Inconvenience regretted.
Accurate diagnostic tests play a key role in patient management and the control of most dangerous diseases. A major outreach effort made by combining scientific, technological and academic expertise is needed for developing next-generation diagnostic tests.
With a similar vision, Labsystems Diagnostics Oy, a Finnish establishment develops, manufactures, markets and sells high-quality diagnostic tests globally for clinical laboratory use, home use and doctors’ offices. After the acquisition by the India-based global healthcare group Trivitron, Labsystems Diagnostics Oy raised the bars in the In Vitro Diagnostics sector.
Labsystems Diagnostics develops, manufactures and markets high-quality and safe diagnostic products, which are based on defined quality specifications and fulfil relevant regulatory requirements. The strengths of Labsystems Diagnostics are know-how and continuous product development, which we use to respond to clinical needs.
Our quality target is to deliver products fulfilling our quality criteria in agreed time and ensure at all times the patient safetyand the customer satisfaction. To achieve our goals in quality, the whole personnel is conscious about the importance of the high quality.
Labsystems Diagnostics Oy design, development, manufacturing, marketing and sales of reagents and reagent products are in line with several regulations. Equipped with automated robotics assembly and production lines, Labsystems delivers quality in accordance with ISO 13485 and IVDD CE guidelines.